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INTRODUCTORY REMARKS
As usual, the alphabet throws together a mixture 
of supplements with different levels of popular-
ity and scientiﬁ c support. Part 20 covers some 
rarely reported, studied and/or little used supple-
ments in sport: glycine, histidine and inosine. 
The majority of human studies of supplementa-
tion with the essential amino acid histidine has 
involved clinical work. In terms of athletic per-
formance, there is current interest in supplemen-
tation strategies to increase muscle content of the 
histidine-containing dipeptide (HCD), carnos-
ine. Despite some interest in the use of a chicken 
breast extract (CBEX) described in this article, 
most of the focus in this area involves β-alanine 
supplementation (covered in part 5). There was 
some interest in inosine as an ergogenic aid in 
the 1990s but it appears not to have been studied 
since then. Meanwhile, there appears little role 
for glycine supplementation in sport although 
some interest in glycine-containing compounds 
is possible. β-Hydroxymethyl β-butyrate (HMB) 
is much more well known, with marketing usu-
ally targeting bodybuilders.
GLYCINE
K Currell
Glycine is the smallest amino acid; it is non-essen-
tial and can be synthesised from serine. Glycine is 
present in most proteins and is particularly highly 
concentrated in collagen. Consequently, one of the 
highest food sources of glycine is gelatin. Glycine 
is also one of the three amino acid components 
of glutathione, which is a key component of the 
body’s defences against oxidative stress; however, 
it is thought that glycine availability is not the 
limiting step in glutathione synthesis. Glycine 
ingestion increases plasma concentrations of insu-
lin in a similar way to other amino acids.1 Glycine 
is also an inhibitory neurotransmitter.
There is little research on supplementation 
with glycine. Research has looked at its poten-
tial role in decreasing inﬂ ammation.2 Sport 
speciﬁ c research has focused on combining gly-
cine with other nutrients. Glycine-propionyl-L-
carnitine (GPLC) has been shown to inﬂ uence 
exercise performance,3 decrease oxidative stress4 
and potentially increase vasodilation through 
increases in plasma nitrate.4 At present, there is 
insufﬁ cient evidence to suggest the use of glycine 
as a supplement to enhance sporting performance. 
However, further research on the effectiveness of 
GPLC is warranted.
HISTIDINE-CONTAINING DIPEPTIDES
W Derave and I Everaert
Carnosine (β-alanyl-L-histidine) and its methylated 
analogues anserine (β-alanyl-N1-methylhistidine) 
and balenine (β-alanyl-N3-methylhistidine) are 
HCDs present abundantly in mammalian skel-
etal muscles. Carnosine is the only HCD found 
in human skeletal muscles, whereas all three 
HCDs are present in the omnivorous human diet. 
In an attempt to understand the role of carnos-
ine in human muscle, Harris et al5 searched for 
a carnosine loading protocol. They showed that 
β-alanine supplementation (4–6 g/day) for several 
weeks (4–10 weeks) resulted in elevated muscle 
carnosine levels (up to 80%). β-Alanine seems 
to be without adverse effects if the dose of 10 
mg/kg body weight per 2-h interval, which can 
lead to paraesthesia, is not exceeded.5 Hill et al6 
showed that carnosine loading leads to better per-
formance during high-intensity exercise (cycling 
at 110% of Wmax to exhaustion). With the avail-
ability of more recent studies, it becomes evi-
dent that mostly high-intensity efforts that last 
several minutes experience a positive inﬂ uence 
of β-alanine supplementation. Indeed, β-alanine 
was not ergogenic for repeated sprint performance 
(10×5 s sprint),7 while both a simulated 2000-m 
rowing race (±6 min)8 and the sprint at the end 
of 2-h simulated cycling race9 were improved by 
β-alanine. It is plausible that high-intensity per-
formance is affected in long-term vegetarians, as 
they are characterised with lower muscle carnos-
ine levels (−26%). The ergogenic mechanism of 
β-alanine may reside in the attenuation of acidosis 
through the proton-buffering capacity of carnos-
ine, whereas other physiological properties of car-
nosine (antioxidant, calcium sensitisation) cannot 
be excluded at present.10
Besides β-alanine supplementation, CBEX is also 
used, mainly in Japan, to elevate muscle carnosine 
stores. CBEX, obtained via hot water extraction of 
chicken breast, is a rich source of HCD, like anser-
ine (1.4 g/100 ml) and carnosine (0.6 g/100 ml). An 
increase in the muscle carnosine content is likely 
to occur as a result of chronic CBEX supplementa-
tion. Long-term CBEX supplementation enhanced 
the time to exhaustion at the last spurt of a rela-
tively high-intensity endurance performance.11 
Suzuki et al12 showed that the acute supplementa-
tion with CBEX (0.4 g carnosine+1.1 g anserine) 
30 min before 10×5 s repeated sprints, decreased 
the bicarbonate buffering in blood but did not affect 
performance. The effect of acute supplementation 
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with HCD on blood buffering and high-intensity exercise per-
formance needs further investigation.
In conclusion, an increment in muscle carnosine levels, 
either by chronic β-alanine or CBEX supplementation, seems 
to be ergogenic mainly in high-intensity exercise lasting sev-
eral minutes.
INOSINE
L McNaughton
Inosine is a nucleoside formed when hypoxanthine is 
attached to a ribose ring (also known as a riobfuranose) via a 
β-N9-glycosidic bond. Inosine plays a role in several metabolic 
functions including increasing red blood cell concentrations of 
2,3-diphosphoglycerate (2,3-DPG), which is involved in oxy-
gen transport.13 It may also potentiate the action of endoge-
nously formed adenosine and inhibit its uptake and clearance. 
It has been proposed to enhance exercise performance via the 
effects on 2,3-DPG or by an increase in ATP concentrations.14
Little scientiﬁ c investigation has been conducted on inos-
ine as an ergogenic aid and few peer-reviewed papers could 
be found. The available studies involving trained individu-
als investigated chronic intakes of large doses of inosine 
(eg, 5–10 000 mg/day), but these protocols did not provide an 
ergogenic effect for endurance15 16 or sprint activities.17 It is sug-
gested that high-dose inosine, a uric acid precursor, combined 
with high urinary excretion, could be detrimental and result 
in kidney stones or acute renal failure.17 In summary, there 
appears to be little support for the use of inosine as an ergo-
genic aid though it is still used in some over-the-counter ﬁ tness 
products. There are continuing clinical trials that may indicate 
a future therapeutic effect as an antioxidant for exercise.
HYDROXYMETHYL BUTYRATE
G Slater
HMB is a metabolite of the essential branched chain amino 
acid leucine, via α-ketoisocaproate, the transamination prod-
uct of leucine. Approximately 2–10% of leucine oxidation 
proceeds to HMB. Much initial research on HMB focused on 
animals, assessing effects on immune function, morbidity 
and mortality, colostral milk fat content, growth rates, safety 
and toxicity. Despite unconvincing results in animal research, 
HMB supplementation was used in humans in the mid-1990s 
on the presumption that it might enhance gains in muscle 
size and strength while reducing muscle damage and sore-
ness associated with resistance training,18 and possibly also 
enhance aerobic capacity.
Supplementation with either 1.5 or 3.0 g/day of HMB had 
a favourable impact on indirect indices of muscle protein 
breakdown and muscle damage, with concomitant trends 
for enhanced strength and skeletal muscle hypertrophy.18 
Consequently, the popularity of HMB supplementation 
increased dramatically, becoming one of the top supplements 
used by athletes in the late 1990s.19 More recently, interest in 
HMB supplementation among athletes has probably declined. 
Despite this, HMB research reports within the sports envi-
ronment continue to emerge. There are several recent HMB 
reviews,20 21 with results of resistance training research from 
2001 to 2007 consolidated into two meta-analyses.22 23 Nissen 
and Sharp22 concluded that HMB supplementation augmented 
lean mass and strength gains associated with resistance train-
ing, although the magnitude of effect was trivial (0.28% 
increase in lean mass gain per week). Rowlands and Thomson23 
identiﬁ ed similar small beneﬁ ts from HMB supplementation 
in untrained males but effects were trivial for strength and 
non-existent for body composition in trained lifters.
This disparity in responsiveness to HMB supplementation 
relative to resistance training status might be expected, given 
the suppression in skeletal muscle protein breakdown as a con-
sequence of resistance training adaptations.24 Furthermore, if 
HMB does enhance net protein balance following resistance 
training as a consequence of reducing protein degradation, any 
effect on adaptations is likely to be blunted compared with 
interventions that enhance protein synthesis as the protein 
synthetic response is many times more sensitive to nutri-
tion interventions than degradation.25 An exception may be 
in clinical conditions such as cancer in which skeletal muscle 
atrophy results from an elevation in skeletal muscle protein 
breakdown.26
Short-term HMB supplementation appears to be safe, with 
daily doses equivalent to approximately 6 g/day (76 mg/kg) 
having no impact on indices of hepatic, renal or immune 
function.20
Based on current available reports, the potential for HMB 
supplementation to enhance strength training adaptations 
appears to be small in previously untrained individuals and 
negligible in resistance-trained athletes. Given that the protein 
synthetic response is much more sensitive to nutrition interven-
tions than protein breakdown, the resistance-trained athlete 
is advised to focus on proven strategies such as post- exercise 
ingestion of high biological value proteins rich in leucine to 
maximise adaptation to the resistance training stimulus.
CONCLUDING COMMENTS
While there is probably little reason to study (or take) glycine, 
histidine or inosine supplements, some investigation of other 
compounds containing these molecules may be warranted. In 
the case of histidine, there is good reason to try to enhance 
muscle storage of the HCD, carnosine, but the most common 
and effective supplement to achieve this is β-alanine rather 
than histidine or carnosine per se. Finally, there is evidence 
that supplementation with HMB offers some assistance in 
reducing the breakdown of muscle protein. However, the best 
application of this appears to be in clinical situations involv-
ing high levels of catabolism, such as cancer, rather than in 
athletic populations since strategies to increase muscle size 
and strength in resistance-trained groups are more effectively 
targeted at increasing protein synthesis.
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